Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
FR0013333077
Tue, 15.04.2025
Affluent Medical SA
Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women
SPHINX pilot study in women is set to launch across Europe in H2 2025.
Preparatory evaluations using robotic-assisted implantation confirm that the minimally invasive procedure in women is feas [ … ]
Tue, 11.03.2025
Affluent Medical SA
Affluent Medical announces several key appointments for Medical and Clinical affairs.
Appointment of Dr. Howard C. Herrmann as strategic Chief Medical Officer for structural heart platform.
Appointment of Pr. Nicolas Barry Delongchamps as strategic Chief Medical Officer for Urology platform.
Federica Azzimonti joins as Director of Clinical Oper [ … ]
Tue, 25.02.2025
Affluent Medical SA
Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors
Aix-en-Provence, February 25, 2025 – 5:45 p.m. CET – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME – “Affluent”), a French clinical-stage medical technology company specializing in the international develop [ … ]
Thu, 30.01.2025
Affluent Medical SA
Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase
Completion of the pilot phase of the European multicenter clinical study in humans with the successful 10th minimally invasive implantation of the Artus urinary sphincter.
100% successful activation of implanted dev [ … ]